BeOne Medicines AG

Common Name
BeOne Medicines
Country
Switzerland
Sector
Healthcare
Industry
Biotechnology
Employees
11,000
Ticker
688235
Exchange
SHANGHAI STOCK EXCHANGE
Description
Beigene Ltd. is a global biotechnology company dedicated to developing and commercializing innovative molecularly-targeted and immuno-oncology drugs for the treatment of cancer. The company is heavily...

BeOne Medicines Waste Data Preview

In 2023, BeOne Medicines conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards. The company provided a breakdown of its waste by type (hazardous vs non-hazardous) and treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.

Metric (tonnes)2023202220212020 - 2017
Total Waste Generated
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Total Waste Recovered
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Hazardous Waste Generated
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Non-Hazardous Waste Disposed
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Download BeOne Medicines's Waste Management data for free

Create your Tracenable account today and download up to 5 company datasets of your choice for free. No credit card required.

Verified Sources Behind BeOne Medicines’s Waste Management Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore BeOne Medicines’s data sources below and access millions more through our Disclosure Search.

a. BeOne Medicines's ESG Report 2023
Trace every data point back to BeOne Medicines’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Insights into BeOne Medicines’s Generation of Hazardous and Non-Hazardous Waste

In 2023, BeOne Medicines generated a total of 1,393 metric tonnes of waste. a

Of this amount, 48.67% of BeOne Medicines's total waste generated of was classified as hazardous waste, characterized by properties such as toxicity, flammability, corrosiveness, or reactivity that may pose risks to human health, ecosystems, or the environment. 51.33% was identified as non-hazardous waste, generally considered less harmful and subject to lighter regulatory controls. a

BeOne Medicines’s Hazardous vs Non-Hazardous Waste Over Time

20212022202303507001.05 k1.4 ktonnes
  • Total Non-Hazardous Waste Generated
  • Total Hazardous Waste Generated

How BeOne Medicines reduced the environmental impact of its waste?

Since 2021, BeOne Medicines's total waste generation increased by 100.43%, including a 33.05% rise in 2023, reflecting a persistent upward trend that could be linked to operational growth, inefficient material use, or limited investment in waste prevention systems. a

Over the same period, BeOne Medicines reduced the hazardousness of its waste by 18.29%, with a further 4.21% decline in 2023, suggesting a sustained and meaningful shift toward safer waste profiles and lower environmental impact. a

Overall, BeOne Medicines is generating more waste but has significantly reduced the share of hazardous materials, suggesting a partial decoupling of volume and toxicity that could reflect more responsible inputs or enhanced treatment. a

Want Full Access to BeOne Medicines's Waste Management Dataset?
Sign Up